Overview
Crisponi syndrome, also known as cold-induced sweating syndrome type 1 (CISS1), is an extremely rare autosomal recessive disorder caused by mutations in the CRLF1 (cytokine receptor-like factor 1) gene on chromosome 19p13. It was first described in Sardinian families and primarily affects the autonomic nervous system, musculoskeletal system, and thermoregulatory mechanisms. The condition is characterized by neonatal onset of distinctive facial features, muscular contractions of facial muscles resembling trismus (jaw clenching) triggered by tactile stimulation, feeding difficulties, hyperthermia, and episodes of unexplained high fever. Affected infants often display camptodactyly (flexion contractures of the fingers), broad nose, full cheeks, and a characteristic pursed-lip facial appearance. In the neonatal period, Crisponi syndrome carries a high mortality risk, primarily due to hyperthermia and respiratory complications. Infants who survive the critical neonatal period may develop a phenotype that overlaps significantly with cold-induced sweating syndrome (CISS), characterized by profuse sweating of the face and upper body in response to cold temperatures, progressive scoliosis, and feeding difficulties. The trismus and muscular contractions typically improve with age in surviving patients. There is currently no specific or curative treatment for Crisponi syndrome. Management is supportive and symptomatic, focusing on careful thermoregulation, nutritional support (often requiring nasogastric or gastrostomy tube feeding), monitoring and management of respiratory complications, and physical therapy for musculoskeletal manifestations. Antipyretic measures and environmental temperature control are critical in the neonatal period. Genetic counseling is recommended for affected families. The recognition that Crisponi syndrome and cold-induced sweating syndrome represent a clinical continuum caused by CRLF1 mutations has improved understanding and long-term prognostication for affected individuals.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Crisponi syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Crisponi syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Crisponi syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Crisponi syndrome.
Community
No community posts yet. Be the first to share your experience with Crisponi syndrome.
Start the conversation →Latest news about Crisponi syndrome
No recent news articles for Crisponi syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Crisponi syndrome
What is Crisponi syndrome?
Crisponi syndrome, also known as cold-induced sweating syndrome type 1 (CISS1), is an extremely rare autosomal recessive disorder caused by mutations in the CRLF1 (cytokine receptor-like factor 1) gene on chromosome 19p13. It was first described in Sardinian families and primarily affects the autonomic nervous system, musculoskeletal system, and thermoregulatory mechanisms. The condition is characterized by neonatal onset of distinctive facial features, muscular contractions of facial muscles resembling trismus (jaw clenching) triggered by tactile stimulation, feeding difficulties, hyperthermi
How is Crisponi syndrome inherited?
Crisponi syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Crisponi syndrome typically begin?
Typical onset of Crisponi syndrome is neonatal. Age of onset can vary across affected individuals.